Lim, Jia Jia, Jones, Claerwen M, Loh, Tiing Jen, Dao, Hien Thy, Tran, Mai T, Tye-Din, Jason A, La Gruta, Nicole L and Rossjohn, Jamie ![]() ![]() |
![]() |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (6MB) |
Abstract
αβ T cell receptors (TCR) co-recognise peptide (p) antigens that are presented by major histocompatibility complex (MHC) molecules. While marked variations in TCR-p-MHC docking topologies have been observed from structural studies, the co-recognition paradigm has held fast. Using HLA-DQ2.5-peptide tetramers, here we identify a TRAV12-1+-TRBV5-1+ G9 TCR from human peripheral blood that binds HLA-DQ2.5 in a peptide-agnostic manner. The crystal structures of TCR-HLA-DQ2.5-peptide complexes show that the G9 TCR binds HLA-DQ2.5 in a reversed docking topology without contacting the peptide, with the TCR contacting the β1 region of HLA-DQ2.5 and distal from the peptide antigen binding cleft. High-throughput screening of HLA class I and II molecules finds the G9 TCR to be pan-HLA-DQ2 reactive, with leucine-55 of HLA-DQ2.5 being a key determinant underpinning G9 TCR specificity excluding other HLA-II allomorphs. Consistent with the functional assays, the interactions of the G9 TCR and HLA-DQ2.5 precludes CD4 binding, thereby impeding T cell activation. Collectively, we describe a naturally selected αβTCR from human peripheral blood that deviates from the TCR-p-MHC co-recognition paradigm.
Item Type: | Article |
---|---|
Date Type: | Published Online |
Status: | Published |
Schools: | Schools > Medicine |
Additional Information: | License information from Publisher: LICENSE 1: Title: cc by, Type: cc by |
Publisher: | Nature Research |
ISSN: | 2041-1723 |
Date of First Compliant Deposit: | 22 April 2025 |
Date of Acceptance: | 1 April 2025 |
Last Modified: | 22 Apr 2025 11:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/177816 |
Actions (repository staff only)
![]() |
Edit Item |